trending Market Intelligence /marketintelligence/en/news-insights/trending/1pq-r44pmbf-6v69vl75fw2 content esgSubNav
In This List

Zosano appoints board member from private equity firm

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zosano appoints board member from private equity firm

Zosano Pharma Corp. appointed Steven Elms to its board of directors.

The Fremont, Calif.-based biopharmaceutical company said Elms serves as managing partner at Aisling Capital, which was the lead investor in its $50 million follow-on offering completed in April.